Shuttle Pharmaceuticals

(NASDAQ) SHPH

Current Price$4.13

Market Cap$2.86M

Since IPO (2022)-100%

5 YearN/A

1 Year-93%

1 Month-36%

Shuttle Pharmaceuticals Financials at a Glance

Market Cap

$2.86M

Revenue (TTM)

$0.00

Net Income (TTM)

-$10.82M

EPS (TTM)

-$6.06

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.13

Volume

755

Open

$4.21

Price

$4.13

Volume

755

Open

$4.21

Previous Close

$4.13

Daily Range

$4.02 - $4.43

52-Week Range

$0.38 - $55.90

Estimated Earnings Date

May 14, 2026

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$4.13

Volume

755

Open

$4.21

Previous Close

$4.13

Daily Range

$4.02 - $4.43

52-Week Range

$0.38 - $55.90

Estimated Earnings Date

May 14, 2026

SHPH News

healthcare lab treatment research scientist

Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week

James HalleySep 9, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Shuttle Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Christopher Robert Cooper, MBA

Website

www.shuttlepharma.com

Headquarters

Gaithersburg, MD 20850, US

SHPH Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-326%

Return on Capital

-3%

Return on Assets

-92%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.86M

Shares Outstanding

5.85M

Volume

755

Avg. Volume

1.38M

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$11.92M

EBITDA

-$11.36M

Operating Cash Flow

-$9.48M

Capital Expenditure

$5.00

Free Cash Flow

-$9.48M

Cash & ST Invst.

$334.01K

Total Debt

$232.15K

Shuttle Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$633.34K

N/A

Gross Margin

0.00%

N/A

Market Cap

$2.86M

N/A

Market Cap/Employee

$317.92K

N/A

Employees

N/A

Net Income

-$2.15M

+29.5%

EBITDA

-$1.51M

+50.4%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$1.09M

-75.8%

Total Debt

$214.01K

-80.6%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$134.05K

-39.1%

Short Term Debt

$79.96K

-91.0%

Return on Assets

-91.63%

N/A

Return on Invested Capital

-3.19%

N/A

Free Cash Flow

-$2.42M

+4.3%

Operating Cash Flow

-$2.42M

+4.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RDHLRedHill Biopharma Ltd.

RDHLRedHill Biopharma Ltd.$0.92+4.66%

BBLGBone Biologics Corporation

BBLGBone Biologics Corporation$1.27+2.42%

UPCUniverse Pharmaceuticals Inc.

UPCUniverse Pharmaceuticals Inc.$3.25-10.47%

HSCSHeartSciences Inc.

HSCSHeartSciences Inc.$1.88+0.00%

IMCCIM Cannabis Corp.

IMCCIM Cannabis Corp.$0.25+7.06%

AKANAkanda Corp.

AKANAkanda Corp.$15.39+11.44%

ISPCiSpecimen Inc.

ISPCiSpecimen Inc.$2.75+2.61%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.65+0.09%

SPCEVirgin Galactic

SPCEVirgin Galactic$5.73+0.22%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.83-0.10%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.01+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.04-0.05%

QQQInvesco QQQ Trust

QQQInvesco QQQ Trust$717.12+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.12+0.09%

Questions About SHPH

What is the current price of Shuttle Pharmaceuticals?

Shuttle Pharmaceuticals is trading at $4.13 per share.

What is the 52-week range for Shuttle Pharmaceuticals?

Over the past 52 weeks, Shuttle Pharmaceuticals has traded between $0.38 and $55.90.

How much debt does Shuttle Pharmaceuticals have?

As of the most recent reporting period, Shuttle Pharmaceuticals reported total debt of $214.01K.

How much cash does Shuttle Pharmaceuticals have on hand?

Shuttle Pharmaceuticals reported $1.09M in cash and cash equivalents in its most recent financial results.

What is Shuttle Pharmaceuticals’s dividend yield?

Shuttle Pharmaceuticals does not currently have a dividend yield.

Shuttle Pharmaceuticals

Shuttle Pharmaceuticals Financials at a Glance

SHPH News

Why Shares of Shuttle Pharmaceuticals Jumped 160.4% This Week

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Shuttle Pharmaceuticals

SHPH Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Shuttle Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About SHPH

What is the current price of Shuttle Pharmaceuticals?

What is the 52-week range for Shuttle Pharmaceuticals?

How much debt does Shuttle Pharmaceuticals have?

How much cash does Shuttle Pharmaceuticals have on hand?

What is Shuttle Pharmaceuticals’s dividend yield?

Premium Investing Services